First-in-human phase I study of a selective c-Met inhibitor volitinib (HMP504/AZD6094) in patients with advanced solid tumors. Conference Paper uri icon

authors

  • Gan, Hui Kong
  • Lickliter, Jason
  • Millward, Michael
  • Gu, Yi
  • SU, Weiguo
  • Frigault, Melanie
  • Qi, Chuan
  • MU, Hua

publication date

  • May 20, 2014